Parschauer Karah Herdman 4

What Happened Karah Parschauer, Executive Vice President and Chief Legal Officer of Ultragenyx Pharmaceutical (RARE), sold a total of 9,526 shares in two transactions. On 2026-03-06 she sold 6,018 shares at $21.40 each for $128,785; on 2026-03-10 she sold 3,508 shares at $22.67 each for $79,526. Both transactions are reported as sales (open market/private sale).

Key Details

• Transaction dates and prices:
  • 2026-03-06: 6,018 shares @ $21.40 = $128,785
  • 2026-03-10: 3,508 shares @ $22.67 = $79,526
• Total sold: 9,526 shares for ~$208,311.
• Shares owned after transaction: not specified in the summary data provided in this request (noted ownership balance not included).
• Footnote F1: reported holdings include previously disclosed common stock underlying RSUs that remain subject to certain vesting conditions.
• Filing: Form 4 filed 2026-03-10 covering the 2026-03-06 transaction; filing appears timely (within required reporting window).

Context

• These were outright sales (coded "S"), which are often routine disposition activity and do not by themselves indicate management sentiment about the company’s prospects. Purchases generally carry stronger signals than sales.
• Footnote F1 means some of the insider’s reported holdings may reflect restricted stock units that have not fully vested; that can affect how much of the position is actually liquid.
• No indication in this filing of option exercises, gifts, or 10b5-1 plan language; no speculation on motive is made here.